Regional
National Emergency Medical Services
The current listed document is more than 24 months old and may be outdated.
Drugs and doses38
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride7
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 15 mg/kg | PO | not captured | standing | pages 92, 93 |
| Pediatric fever | peds | 15 mg/kg | PO | not captured | standing | pages 21, 92, 93 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 mg | IV | not captured | standing | page 36 |
| Other | adult | 6 mg | IV | not captured | standing | pages 94, 95, 170 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 94, 95, 170 |
| SVT | adult | 6 mg | IV | not captured | standing | pages 36, 94, 95, 170 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | pages 36, 94, 95, 170 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5–5 mg | NEB | not captured | standing | pages 25, 26, 27, 52, 96 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 25, 26, 27, 52, 96 |
| COPD | adult | 2.5 mg | NEB | not captured | standing | page 27 |
| Hyperkalemia | adult | 5 mg | NEB | not captured | standing | pages 61, 69 |
| Other | adult | 2.5–5 mg | NEB | not captured | standing | page 96 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 25 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 52 |
| Other | adult | 5 mg | NEB | not captured | standing | page 61 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 26 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 52 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 96 |
| Other | peds | 5 mg | NEB | not captured | standing | page 96 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 97, 98 |
| Other | adult | 300 mg | IV/IO | not captured | standing | pages 97, 99 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 97, 99 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 97, 98 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 36, 97, 99 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 36, 97, 99 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 39, 97, 99 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 39, 97, 99 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 39, 97, 99 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 39, 97, 99 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 32, 100 |
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 32, 100 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 44 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 44 |
| Bradycardia | adult | 0.5 mg | IV/IO | not captured | standing | pages 33, 34, 101, 102 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 33, 34, 101, 102 |
| Organophosphate poisoning | adult | 2 mg | IV/IO/IM | not captured | standing | pages 78, 86, 101, 102 |
| Organophosphate poisoning | adult | 2 mg | IV/IO | not captured | standing | page 78 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO/IM | not captured | standing | pages 78, 86, 101, 102 |
| Organophosphate poisoning | peds | 0.04 mg/kg | ET | not captured | standing | page 101 |
| Other | adult | 1 mg | IV/IO | not captured | standing | page 33 |
| Other | peds | 0.02 mg/kg | IV | not captured | standing | page 44 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 101, 102 |
| Other | peds | 0.04–0.06 mg/kg | ET | not captured | standing | pages 101, 102 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | pages 40, 44, 103, 104 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | pages 40, 44, 103, 104 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 40, 61, 103, 104 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 40 |
| Hyperkalemia | adult | 1000 mg | IV/IO | not captured | standing | page 61 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | pages 40, 61, 103, 104 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 103 |
| Other | peds | 20 mg/kg | IV | not captured | standing | page 44 |
D–F Dextrose, Diazepam, Diltiazem, Diphenhydramine, Epinephrine, Etomidate, Fentanyl, Furosemide8
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 25 g | IV/IO | not captured | standing | page 105 |
| Hypoglycemia | adult | 12.5 g | IV/IO | not captured | standing | pages 60, 105, 106 |
| Hypoglycemia | adult | 12.5 g | IV/IO | not captured | standing | page 105 |
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | page 40 |
| Hypoglycemia | peds | 0.25 g/kg | IV/IO | not captured | standing | page 40 |
| Hypoglycemia | peds | 0.25 g/kg | IV/IO | not captured | standing | page 106 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | pages 60, 105, 106 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | page 106 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | page 105 |
| Other | adult | 25 g | IV/IO | not captured | standing | page 105 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 64 |
| Seizure | adult | 5 mg | IV/IO/IM | not captured | standing | pages 64, 107, 108 |
| Seizure | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | pages 64, 107, 108 |
| Seizure | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | page 107 |
| Seizure | peds | 0.8 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 0.9 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 1 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 1.2 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 1.3 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 1.4 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 1.5 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 1.6 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 1.7 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 1.8 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 1.9 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 2 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 2.2 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 2.6 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 3.2 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 3.8 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 4.4 mg | IV/IO/IM | not captured | standing | page 108 |
| Seizure | peds | 5 mg | IV/IO/IM | not captured | standing | page 108 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 10 mg | IV/IO | not captured | standing | pages 36, 109, 110 |
| Atrial fibrillation with RVR | adult | 10 mg | IV/IO | not captured | standing | pages 109, 110 |
| Other | adult | 10 mg | IV/IO | not captured | standing | page 36 |
| Other | adult | 5 mg | IV/IO | not captured | standing | pages 109, 110 |
| Other | adult | 5 mg | IV/IO | not captured | standing | page 36 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 25–50 mg | IM | not captured | standing | pages 51, 111, 112 |
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | pages 20, 52, 111, 112 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 20, 52, 111, 112 |
| Anaphylaxis | adult | 25–50 mg | IV/IO/IM | not captured | standing | pages 52, 111, 112 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 52, 111, 112 |
| Dystonic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | pages 20, 111, 112 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 20, 111, 112 |
| Other | adult | 10 mg | IV/IO/IM | not captured | standing | pages 78, 86 |
| Other | adult | 25–50 mg | IV/IO/IM | not captured | standing | pages 111, 112 |
| Other | adult | 25–50 mg | IV/IM | not captured | standing | page 20 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 20 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 78, 86 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 111, 112 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 52, 113 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 52, 113 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 52, 113 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | pages 25, 113 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | pages 25, 113 |
| Bradycardia | adult | 2.5–10 mcg | IV/IO | not captured | standing | pages 33, 34, 113, 115 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 33, 34, 113, 115 |
| Bradycardia | peds | 0.01 mg/kg | IV | not captured | standing | pages 34, 113, 116 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 39, 43, 113, 116 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 39, 43, 113, 116 |
| Croup | peds | 2.5 mL | NEB | not captured | standing | page 113 |
| Other | adult | 0.3 mg | IM/SQ | not captured | standing | page 113 |
| Other | adult | 100 mcg | IV/IO | not captured | standing | page 113 |
| Other | peds | 0.01 mg/kg | SQ | not captured | standing | page 113 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 113, 116 |
| Other | peds | 0.3 mg | IM | not captured | standing | page 113 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 28, 121 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1–2 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 21, 122, 123 |
| Mild to moderate pain | adult | 1–2 mcg/kg | not captured | not captured | standing | page 21 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 21, 122, 123 |
| Mild to moderate pain | peds | 1 mcg/kg | not captured | not captured | standing | page 21 |
| Severe pain | adult | 1–2 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 122, 123 |
| Severe pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 122, 123 |
| Procedural sedation | adult | 1–2 mcg/kg | IV/IO | not captured | standing | pages 28, 122 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | pages 57, 124 |
| Other | adult | 40 mg | IV | not captured | standing | page 57 |
| Other | adult | 40 mg | IV/IO | not captured | standing | page 124 |
G–L Glucagon, Haloperidol, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam9
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 5–10 mg | IV/IO | not captured | standing | pages 40, 44, 125 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 5–10 mg | IV/IO | not captured | standing | pages 40, 125 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5 mg | IV/IO | not captured | standing | pages 40, 44, 125 |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | pages 40, 44, 60, 125 |
| Hypoglycemia | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 40, 44, 60, 125 |
| Hypoglycemia | peds | 0.5 mg | IM/IN | not captured | standing | pages 60, 125 |
| Other | adult | 1 mg | IV/IO | not captured | standing | page 125 |
| Other | adult | 1–2 mg | IV/IO/IM | not captured | standing | page 78 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 78 |
| Other | peds | 0.5 mg | IV | not captured | standing | page 44 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IM | not captured | standing | pages 51, 126, 127 |
| Agitation | peds | 0.15 mg/kg | IM | not captured | standing | pages 51, 126, 127 |
| Other | adult | 5 mg | IM | not captured | standing | pages 126, 127 |
| Other | peds | 0.15 mg/kg | IM | not captured | standing | pages 126, 127 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 10 mg/kg | PO | not captured | standing | pages 128, 129 |
| Pediatric fever | peds | 10 mg/kg | PO | not captured | standing | pages 21, 85, 128, 129 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 25, 26, 27, 52, 130 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 25, 26, 27, 52, 130 |
| Other | adult | 0.5 mg | NEB | not captured | standing | pages 25, 26, 27, 52, 130 |
| Other | peds | 0.5 mg | NEB | not captured | standing | pages 25, 26, 27, 52, 130 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.25 mg/kg | IV/IO/IM | not captured | standing | pages 21, 131 |
| Mild to moderate pain | adult | 0.25 mg/kg | IV/IO/IM | not captured | standing | page 21 |
| Mild to moderate pain | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 131 |
| Mild to moderate pain | peds | 0.25 mg/kg | IV/IO/IM | not captured | standing | pages 21, 131 |
| Mild to moderate pain | peds | 0.25 mg/kg | IV/IO/IM | not captured | standing | page 21 |
| Mild to moderate pain | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 131 |
| RSI induction | adult | 2 mg/kg | IV | not captured | standing | pages 28, 131 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 60 mg | IM | not captured | standing | page 132 |
| Mild to moderate pain | adult | 15 mg | IV/IO | not captured | standing | page 132 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 132 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 20 mg | IV | not captured | standing | pages 88, 133 |
| Other | adult | 10 mg | IV | not captured | standing | pages 88, 133 |
| Other | adult | 10 mg | IV | not captured | standing | page 62 |
| Other | adult | 20 mg | IV | not captured | standing | page 88 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 134 |
| Other | adult | 40 mg | IO | not captured | standing | pages 19, 134 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | pages 134, 135 |
| Other | peds | 0.5 mg/kg (max 40 mg) | IO | not captured | standing | pages 19, 134 |
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | pages 19, 134, 135 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | pages 19, 134, 135 |
| VF / pulseless VT | adult | 1 mg/kg | IV/IO | not captured | standing | pages 134, 135 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 134, 135 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 1–2 mg | IV/IO/IM | not captured | standing | pages 136, 137 |
| Hyperactive delirium | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 136, 137 |
| Other | adult | 1–2 mg | IV/IO/IM | not captured | standing | page 136 |
| Other | adult | 2 mg | IM | not captured | standing | page 51 |
| Other | adult | 2 mg | IV/IO | not captured | standing | page 64 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 64 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 136 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 137 |
| Seizure | adult | 1–2 mg | IV/IO/IM | not captured | standing | pages 64, 136, 137 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 64, 136, 137 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose9
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | pages 25, 27, 138, 139, 140 |
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | pages 138, 139, 140 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV | not captured | standing | pages 25, 27, 138, 139, 140 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV | not captured | standing | pages 138, 139, 140 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | pages 138, 139 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | pages 138, 139 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 40 |
| Other | adult | 2 g | IV | not captured | standing | page 25 |
| Other | adult | 4 g | IV/IO | not captured | standing | pages 64, 88 |
| Other | peds | 40 mg/kg | IV | not captured | standing | page 25 |
| Other | peds | 50 mg/kg | IV/IO | not captured | standing | pages 64, 88 |
| Seizure | peds | 50 mg/kg | IV/IO/IM | not captured | standing | pages 138, 140 |
| Seizure | peds | 50 mg/kg | IV/IO | not captured | standing | page 138 |
| VF / pulseless VT | adult | 2–4 g | IV/IO | not captured | standing | page 138 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | pages 52, 141, 142 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 52, 141, 142 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | pages 25, 141, 142 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 25, 141, 142 |
| COPD | adult | 125 mg | IV/IO/IM | not captured | standing | pages 25, 141, 142 |
| COPD | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 25, 141, 142 |
| Other | peds | 2 mg/kg | not captured | not captured | standing | page 142 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV/IO/IM | not captured | standing | page 21 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 51 |
| Agitation | peds | 0.1 mg/kg | IM | not captured | standing | page 51 |
| Agitation | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 21 |
| Hyperactive delirium | adult | 2.5–5 mg | IV/IO/IM/IN | not captured | standing | pages 143, 144 |
| Hyperactive delirium | peds | 0.2 mg/kg | IV/IO/IM/IN | not captured | standing | pages 143, 144 |
| Other | adult | 0.05 mg/kg | IV/IO | not captured | standing | page 28 |
| Other | adult | 2.5–5 mg | IV/IO/IM/IN | not captured | standing | pages 143, 144 |
| Other | adult | 2.5 mg | IV/IO | not captured | standing | page 32 |
| Other | adult | 2.5 mg | IV/IO/IM/IN | not captured | standing | pages 78, 86 |
| Other | adult | 2.5 mg | IV/IO/IM/IN | not captured | standing | pages 78, 86 |
| Other | adult | 5 mg | IM/IN | not captured | standing | page 64 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 143, 144 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 64 |
| Other | peds | 0.2 mg/kg | IV/IO/IM/IN | not captured | standing | pages 78, 86 |
| Other | peds | 0.2 mg/kg | IV/IO/IM/IN | not captured | standing | pages 143, 144 |
| Other | peds | 0.3 mg/kg | IN | not captured | standing | page 51 |
| Procedural sedation | adult | 2.5 mg | IV/IO | not captured | standing | page 33 |
| Seizure | adult | 2.5–5 mg | IV/IO/IM/IN | not captured | standing | pages 64, 143, 144 |
| Seizure | peds | 0.2 mg/kg | IV/IO/IM/IN | not captured | standing | pages 64, 143, 144 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 4 mg | not captured | not captured | standing | page 21 |
| Mild to moderate pain | peds | 0.1 mg/kg | not captured | not captured | standing | page 21 |
| Severe pain | adult | 4 mg | IV/IO/IM/IN | not captured | standing | pages 21, 145 |
| Severe pain | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 21, 145 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IN | not captured | standing | pages 40, 44, 78, 86, 146 |
| Opioid overdose | adult | 2 mg | IN | not captured | standing | pages 40, 44, 78, 86 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | pages 40, 44, 78, 86 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IN | not captured | standing | pages 40, 44, 78, 86, 146 |
| Other | adult | 1–2 mg | IV/IO/IM/IN | not captured | standing | page 146 |
| Other | peds | 0.1 mg/kg | IV/IO/IN | not captured | standing | page 44 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 146 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 32, 147 |
| ACS / chest pain | adult | 1 inch | TD | not captured | standing | pages 32, 147 |
| Other | adult | 0.4 mg | SL | not captured | standing | pages 57, 147 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 32 |
| Other | adult | 1 inch | TD | not captured | standing | page 32 |
| Other | adult | 1 inch | TD | not captured | standing | pages 57, 147 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 5–30 mcg | IV/IO | not captured | standing | pages 27, 32, 41, 57, 63, 148, 149, 150 |
| Hypotension / shock | peds | 0.1–1 mcg/kg | IV/IO | not captured | standing | pages 27, 32, 41, 57, 63, 148, 149, 150 |
| Other | adult | 0.02–2 mcg/kg | not captured | not captured | standing | page 27 |
| Other | adult | 5–30 mcg | IV/IO | not captured | standing | pages 27, 32, 41, 57, 63, 148, 149, 150 |
| Other | adult | 5–30 mcg | not captured | not captured | standing | page 41 |
| Other | peds | 0.1–1 mcg/kg | IV/IO | not captured | standing | pages 27, 32, 41, 57, 63, 148, 149, 150 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO | not captured | standing | pages 20, 153, 154 |
| Nausea / vomiting | adult | 4 mg | ODT | not captured | standing | pages 20, 153 |
| Nausea / vomiting | adult | 4 mg | IV/IO | not captured | standing | pages 20, 153, 154 |
| Nausea / vomiting | adult | 4 mg | ODT | not captured | standing | pages 20, 153 |
| Nausea / vomiting | adult | 4 mg | IV/ODT | not captured | standing | page 20 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 20, 153, 154 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 20, 153, 154 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/ODT | not captured | standing | page 20 |
| Other | adult | 4 mg | IV/IO | not captured | standing | pages 153, 154 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 153, 154 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15–30 g | PO | not captured | standing | page 60 |
| Hypoglycemia | adult | 15–30 g | PO | not captured | standing | pages 60, 155 |
| Hypoglycemia | peds | 7.5–15 g | PO | not captured | standing | page 60 |
| Hypoglycemia | peds | 7.5–15 g | PO | not captured | standing | pages 60, 155 |
| Other | adult | 15 g | PO | not captured | standing | page 155 |
| Other | peds | 7.5 g | PO | not captured | standing | page 155 |
P–R Prochlorperazine, Racemic Epinephrine2
Prochlorperazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5 mg | IV/IM | not captured | standing | pages 20, 157 |
| Nausea / vomiting | adult | 5 mg | IV/IM | not captured | standing | pages 20, 157 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | pages 20, 157 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | pages 20, 157 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV | not captured | standing | page 20 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Croup | adult | 11.25 mg | NEB | not captured | standing | pages 26, 158 |
| Croup | peds | 0.5 mL | NEB | not captured | standing | pages 26, 158 |
| Stridor | adult | 11.25 mg | NEB | not captured | standing | page 25 |
S–Z Sodium Bicarbonate, Thiamine, Tranexamic Acid3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 40, 159 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 40, 159 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 78, 86, 159 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | pages 69, 159 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 78, 86, 159 |
| Other | peds | 1 mEq/kg | IV | not captured | standing | pages 69, 159 |
| Other | peds | 1 mEq/kg | IV | not captured | standing | page 44 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 40, 78, 86, 159 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 40, 78, 86, 159 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 100 mg | IV/IO | not captured | standing | pages 60, 105, 161 |
| Hypoglycemia | peds | 10–25 mg | IV/IO | not captured | standing | pages 60, 105, 161 |
| Other | adult | 100 mg | IV/IO | not captured | standing | page 60 |
| Other | adult | 100 mg | IV | not captured | standing | page 105 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV | not captured | standing | page 63 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 162 |
| Other | peds | 15 mg/kg | IV/IO | not captured | standing | page 162 |
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | pages 42, 63, 66, 67, 68, 69, 162 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | pages 42, 63, 66, 67, 68, 69, 162 |
Cite this
National Emergency Medical Services, United States EMS Protocol Census. 286 dose entries, effective 2024-09-01.
https://protoquiz.com/census/agencies/national-emergency-medical-services/
The census is free and not for sale. Only public agencies are named.